1
|
Du Berry C, Nesci C, Cheong JL, FitzGerald T, Mainzer R, Ranganathan S, Doyle LW, Vrijlandt EJ, Welsh L. Long-term expiratory airflow of infants born moderate-late preterm: A systematic review and meta-analysis. EClinicalMedicine 2022; 52:101597. [PMID: 35923430 PMCID: PMC9340512 DOI: 10.1016/j.eclinm.2022.101597] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/07/2022] [Revised: 07/12/2022] [Accepted: 07/13/2022] [Indexed: 11/26/2022] Open
Abstract
BACKGROUND Moderate-late preterm (MLP; 32 to <37 weeks' gestation) birth is associated with reduced expiratory airflow during child, adolescent and adult years. However, some studies have reported only minimal airflow limitation and hence it is unclear if clinical assessment in later life is warranted. Our aim was to compare maximal expiratory airflow in children and adults born MLP with term-born controls, and with expected norms. METHODS We systematically reviewed studies reporting z-scores for spirometric indices (forced expired volume in 1 second [FEV1], forced vital capacity [FVC], FEV1/FVC ratio and forced expiratory flow at 25-75% of FVC [FEF25-75%]) from participants born MLP aged five years or older, with or without a term-born control group from 4 databases (MEDLINE, CINAHL, Embase, Emcare). Publications were searched for between the 22nd of September 2021 to the 29th of September 2021. A meta-analysis of eligible studies was conducted using a random effects model. The study protocol was published in PROSPERO (CRD #42021281518). FINDINGS We screened 4970 articles and identified 18 relevant studies, 15 of which were eligible for meta-analysis (8 with term-born controls and 7 without). Compared with controls, MLP participants had lower z-scores (mean difference [95% confidence interval] I2) for FEV1: -0.22 [-0.35, -0.09] 49.3%, FVC: -0.23 [-0.4, -0.06] 71.8%, FEV1/FVC: -0.11 [-0.20 to -0.03] 9.3% and FEF25-75%: -0.27 [-0.41 to -0.12] 21.9%. Participants born MLP also had lower z-scores, on average, when compared with a z-score of 0 (mean [95% CI] I2) for FEV1: -0.26 [-0.40 to -0.11] 85.2%, FVC: -0.18 [-0.34 to -0.02] 88.3%, FEV1/FVC: -0.24 [-0.43 to -0.05] 90.5% and FEF25-75%: -0.33 [-0.54 to -0.20] 94.7%. INTERPRETATION Those born MLP had worse expiratory airflows than those born at term, and compared with norms, although reductions were modest. Clinicians should be aware that children and adults born MLP may be at higher risk of obstructive lung disease compared with term-born peers. FUNDING This work is supported by grants from the National Health and Medical Research Council (Centre of Research Excellence #1153176, Project grant #1161304); Medical Research Future Fund (Career Development Fellowship to J.L.Y Cheong #1141354) and from the Victorian Government's Operational Infrastructure Support Programme. C. Du Berry's PhD candidature is supported by the Melbourne Research Scholarship and the Centre of Research Excellence in Newborn Medicine.
Collapse
Affiliation(s)
- Cassidy Du Berry
- Department of Paediatrics, The University of Melbourne, Australia
- Respiratory Group, Infection and Immunity, Murdoch Children's Research Institute, Parkville, Australia
- Department of Respiratory Medicine, The Royal Children's Hospital Melbourne, Australia
- Corresponding author at: Department of Paediatrics, The University of Melbourne, 50 Flemington Road, Parkville, Victoria, 3052, Australia.
| | - Christopher Nesci
- Department of Respiratory Medicine, The Royal Children's Hospital Melbourne, Australia
| | - Jeanie L.Y. Cheong
- Department of Obstetrics and Gynaecology, The University of Melbourne, Australia
- Victorian Infant Brain Studies Group, Clinical Sciences, Murdoch Children's Research Institute, Parkville, Australia
- Newborn Research, The Royal Women's Hospital Melbourne, Australia
| | - Tara FitzGerald
- Department of Physiotherapy, The University of Melbourne, Australia
- Victorian Infant Brain Studies Group, Clinical Sciences, Murdoch Children's Research Institute, Parkville, Australia
| | - Rheanna Mainzer
- Department of Paediatrics, The University of Melbourne, Australia
- Respiratory Group, Infection and Immunity, Murdoch Children's Research Institute, Parkville, Australia
- Clinical Epidemiology and Biostatistics Unit, Population Health, Murdoch Children's Research Institute, Australia
| | - Sarath Ranganathan
- Department of Paediatrics, The University of Melbourne, Australia
- Respiratory Group, Infection and Immunity, Murdoch Children's Research Institute, Parkville, Australia
- Department of Respiratory Medicine, The Royal Children's Hospital Melbourne, Australia
| | - Lex W. Doyle
- Department of Paediatrics, The University of Melbourne, Australia
- Department of Obstetrics and Gynaecology, The University of Melbourne, Australia
- Victorian Infant Brain Studies Group, Clinical Sciences, Murdoch Children's Research Institute, Parkville, Australia
- Newborn Research, The Royal Women's Hospital Melbourne, Australia
| | - Elianne J.L.E. Vrijlandt
- Department of Pediatric Pulmonology and Pediatric Allergy, Beatrix Children's Hospital, and the Groningen Research Institute for Asthma and COPD, the Netherlands
- University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
| | - Liam Welsh
- Department of Paediatrics, The University of Melbourne, Australia
- Respiratory Group, Infection and Immunity, Murdoch Children's Research Institute, Parkville, Australia
- Department of Respiratory Medicine, The Royal Children's Hospital Melbourne, Australia
| |
Collapse
|